Physician profile
Steven B Chen
NPI 1205828597
$12,964.38
in general payments reported to CMS, 2019-2025
34 companies · $3,335 in 2025
The $3,335 reported for 2025 was more than what 94% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $234 · 2020: $270 · 2021: $2,541 · 2022: $3,570 · 2023: $1,324 · 2024: $1,691 · 2025: $3,335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,898 · Travel and Lodging: $1,452.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,898.23 |
| Travel and Lodging | $1,451.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $3,729.73 | 2021-2025 | Stravix Mesh, Stravix, Stravix Pl |
| Ossio INC | $1,838.57 | 2021 | |
| Treace Medical Concepts, INC. | $1,712.69 | 2025 | |
| Organogenesis INC. | $1,627.52 | 2020-2025 | Puraply, Apligraf, Cygnus Dual |
| Convatec INC. | $1,175.98 | 2023-2025 | |
| Paratek Pharmaceuticals, INC. | $841.57 | 2021-2025 | Nuzyra |
| Amgen INC. | $271.94 | 2024-2025 | Krystexxa |
| Nevro Corp. | $257.63 | 2021-2023 | Senza |
| Averitas Pharma INC. | $208.87 | 2024-2025 | Qutenza |
| Kerecis Limited | $173.09 | 2020-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Abbvie INC. | $131.87 | 2021-2024 | Dalvance |
| Osteomed LLC | $108.74 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $108.45 | 2021-2024 | Tapestry |
| Rikco International, LLC | $88.00 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $72.18 | 2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $63.30 | 2022-2024 | Asnis |
| Acumed LLC | $60.99 | 2022-2024 | Osteomed, Acumed |
| Paladin Technology Solutions | $57.02 | 2023-2024 | |
| Paragon 28, INC. | $50.29 | 2019-2022 | |
| Melinta Therapeutics, LLC | $44.50 | 2019 | |
| Merck Sharp & Dohme LLC | $41.86 | 2019 | |
| Horizon Therapeutics Plc | $41.03 | 2023 | Krystexxa |
| Progenacare Global, LLC | $35.02 | 2023-2024 | |
| Nabriva Therapeutics, Plc | $31.48 | 2021-2022 | |
| Ibsa Pharma INC. | $29.53 | 2021-2024 | Tirosint, Licart |
| Solventum Corporation | $26.66 | 2025 | Activ.A.C. |
| Lifenet Health | $23.21 | 2023 | |
| Grt US Holding, INC. | $22.94 | 2022 | |
| Kci USA, INC. | $18.78 | 2020 | |
| Orthofix Medical, INC. | $16.59 | 2024 | Physio-Stim |
| Biotissue Holdings INC. | $15.94 | 2022 | |
| Bioventus LLC | $14.83 | 2022 | |
| Anika Therapeutics, INC. | $12.80 | 2022 | |
| Cashflow Solutions, LLC | $10.78 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.